Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

CD Maps-Dynamic Profiling of CD1-CD100 Surface Expression on Human Leukocyte and Lymphocyte Subsets

T. Kalina, K. Fišer, M. Pérez-Andrés, D. Kuzílková, M. Cuenca, SJW. Bartol, E. Blanco, P. Engel, MC. van Zelm,

. 2019 ; 10 (-) : 2434. [pub] 20191023

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028781

CD molecules are surface molecules expressed on cells of the immune system that play key roles in immune cell-cell communication and sensing the microenvironment. These molecules are essential markers for the identification and isolation of leukocytes and lymphocyte subsets. Here, we present the results of the first phase of the CD Maps study, mapping the expression of CD1-CD100 (n = 110) on 47 immune cell subsets from blood, thymus, and tonsil using an eight-color standardized EuroFlow approach and quantification of expression. The resulting dataset included median antibody binding capacities (ABCs) and percentage of positivity for all markers on all subsets and was developed into an interactive CD Maps web resource. Using the resource, we examined differentially expressed proteins between granulocyte, monocyte, and dendritic cell subsets, and profiled dynamic expression of markers during thymocyte differentiation, T-cell maturation, and between functionally distinct B-cell subset clusters. The CD Maps resource will serve as a benchmark of antibody reactivities ensuring improved reproducibility of flow cytometry-based research. Moreover, it will provide a full picture of the surfaceome of human immune cells and serves as a useful platform to increase our understanding of leukocyte biology, as well as to facilitate the identification of new biomarkers and therapeutic targets of immunological and hematological diseases.

000      
00000naa a2200000 a 4500
001      
bmc20028781
003      
CZ-PrNML
005      
20210114155138.0
007      
ta
008      
210105s2019 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2019.02434 $2 doi
035    __
$a (PubMed)31708916
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kalina, Tomas $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Charles University, Prague, Czechia. Department of Paediatric Haematology and Oncology, University Hospital Motol, Prague, Czechia.
245    10
$a CD Maps-Dynamic Profiling of CD1-CD100 Surface Expression on Human Leukocyte and Lymphocyte Subsets / $c T. Kalina, K. Fišer, M. Pérez-Andrés, D. Kuzílková, M. Cuenca, SJW. Bartol, E. Blanco, P. Engel, MC. van Zelm,
520    9_
$a CD molecules are surface molecules expressed on cells of the immune system that play key roles in immune cell-cell communication and sensing the microenvironment. These molecules are essential markers for the identification and isolation of leukocytes and lymphocyte subsets. Here, we present the results of the first phase of the CD Maps study, mapping the expression of CD1-CD100 (n = 110) on 47 immune cell subsets from blood, thymus, and tonsil using an eight-color standardized EuroFlow approach and quantification of expression. The resulting dataset included median antibody binding capacities (ABCs) and percentage of positivity for all markers on all subsets and was developed into an interactive CD Maps web resource. Using the resource, we examined differentially expressed proteins between granulocyte, monocyte, and dendritic cell subsets, and profiled dynamic expression of markers during thymocyte differentiation, T-cell maturation, and between functionally distinct B-cell subset clusters. The CD Maps resource will serve as a benchmark of antibody reactivities ensuring improved reproducibility of flow cytometry-based research. Moreover, it will provide a full picture of the surfaceome of human immune cells and serves as a useful platform to increase our understanding of leukocyte biology, as well as to facilitate the identification of new biomarkers and therapeutic targets of immunological and hematological diseases.
650    _2
$a dospělí $7 D000328
650    _2
$a CD antigeny $x biosyntéza $7 D015703
650    _2
$a B-lymfocyty $x imunologie $x metabolismus $7 D001402
650    _2
$a separace buněk $7 D002469
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a datové soubory jako téma $7 D066264
650    _2
$a dendritické buňky $x imunologie $x metabolismus $7 D003713
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a granulocyty $x imunologie $x metabolismus $7 D006098
650    _2
$a lidé $7 D006801
650    _2
$a imunofenotypizace $7 D016130
650    _2
$a internet $7 D020407
650    _2
$a leukocyty $x imunologie $x metabolismus $7 D007962
650    _2
$a podskupiny lymfocytů $x imunologie $x metabolismus $7 D016131
650    _2
$a lymfopoéza $7 D038041
650    _2
$a monocyty $x imunologie $x metabolismus $7 D009000
650    _2
$a peptidové mapování $7 D010449
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a T-lymfocyty $x imunologie $x metabolismus $7 D013601
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Fišer, Karel $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Charles University, Prague, Czechia.
700    1_
$a Pérez-Andrés, Martin $u Department of Medicine, Cancer Research Centre (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS), Institute of Biomedical Research of Salamanca, University of Salamanca, Salamanca, Spain. Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
700    1_
$a Kuzílková, Daniela $u CLIP - Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Charles University, Prague, Czechia.
700    1_
$a Cuenca, Marta $u Department of Biomedical Sciences, University of Barcelona, Barcelona, Spain.
700    1_
$a Bartol, Sophinus J W $u Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
700    1_
$a Blanco, Elena $u Department of Medicine, Cancer Research Centre (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS), Institute of Biomedical Research of Salamanca, University of Salamanca, Salamanca, Spain. Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
700    1_
$a Engel, Pablo $u Department of Biomedical Sciences, University of Barcelona, Barcelona, Spain.
700    1_
$a van Zelm, Menno C $u Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands. Department of Immunology and Pathology, Monash University and the Alfred Hospital, Melbourne, VIC, Australia.
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 10, č. - (2019), s. 2434
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31708916 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114155137 $b ABA008
999    __
$a ok $b bmc $g 1609116 $s 1119961
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 10 $c - $d 2434 $e 20191023 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...